Zobrazeno 1 - 10
of 300
pro vyhledávání: '"Zefei Jiang"'
Autor:
Song Wu, Li Bian, Haibo Wang, Shaohua Zhang, Tao Wang, Zhigang Yu, Jianbin Li, Feng Li, Kun Wang, Zefei Jiang
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-10 (2024)
Abstract Background TCbHP (taxane + carboplatin + trastuzumab + pertuzumab) is the preferred neoadjuvant therapy regimen for human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, no consensus exists regarding whether specif
Externí odkaz:
https://doaj.org/article/a30a3b49893548ab977d8c337f316beb
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Current research on the stellate ganglion (SG) has shifted from merely understanding its role as a collection of neurons to recognizing its importance in immune regulation. As part of the autonomic nervous system (ANS), the SG plays a crucial role in
Externí odkaz:
https://doaj.org/article/90e471ac12604761a8a47c635befd77c
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Idiopathic pulmonary fibrosis (IPF) garners considerable attention due to its high fatality rate and profound impact on quality of life. Our study conducts a comprehensive literature review on IPF using bibliometric analysis to explore existing hot r
Externí odkaz:
https://doaj.org/article/05d2147940644252bb4360ed7542e908
Autor:
Yuxuan Gao, Mengmeng Zhang, Gang Sun, Li Ma, Jianyun Nie, Zhongyu Yuan, Zhenzhen Liu, Yali Cao, Jianbin Li, Qiang Liu, Songqing Ye, Bo Chen, Yuhua Song, Kun Wang, Yu Ren, Guolin Ye, Ling Xu, Shu Liu, Qianjun Chen, Weiwen Li, Xinxin Chen, Peifen Fu, Wei Wei, Baoliang Guo, Hebing Wang, Zhenhai Cai, Caiwen Du, Zhiyong Wu, Xiaoming Zha, Heng Huang, Juan Xu, Chenglei Zhang, Yingying Shi, Ting Liu, Sihua Liu, Zefei Jiang, Ying Lin
Publikováno v:
Breast, Vol 76, Iss , Pp 103762- (2024)
Background: Male breast cancer (MBC) is a rare disease. Although several large-scale studies have investigated MBC patients in other countries, the features of MBC patients in China have not been fully explored. This study aims to explore the feature
Externí odkaz:
https://doaj.org/article/6ea2938e673a4a80ae96bab2b536adae
Autor:
Liang Huang, Da Pang, Hongjian Yang, Wei Li, Shusen Wang, Shude Cui, Ning Liao, Yongsheng Wang, Chuan Wang, Yuan-Ching Chang, Hwei-Chung Wang, Seok Yun Kang, Jae Hong Seo, Kunwei Shen, Suphawat Laohawiriyakamol, Zefei Jiang, Haiyan Wang, François Lamour, Grace Song, Michelle Curran, Chunzhe Duan, Sanne Lysbet de Haas, Eleonora Restuccia, Zhimin Shao
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract The randomized, multicenter, double-blind, placebo-controlled, phase III PEONY trial (NCT02586025) demonstrated significantly improved total pathologic complete response (primary endpoint) with dual HER2 blockade in HER2-positive early/local
Externí odkaz:
https://doaj.org/article/483aaf8ea22445929229f4f4bb8b8966
Autor:
Shaohua Zhang, Lili Tang, Chunmei Bao, Siyu Wang, Bo Li, Lei Huang, Hua Song, Junliang Fu, Zhe Xu, Fanping Meng, Lin Cao, Yingying Gao, Yue Yuan, Yangliu Chen, Jinhong Yuan, Chunbao Zhou, Fan Li, Lili Qin, Yingfei Guo, Chao Zhang, Jinwen Song, Xing Fan, Zefei Jiang, Fu‐Sheng Wang, Ruonan Xu
Publikováno v:
Cancer Medicine, Vol 13, Iss 11, Pp n/a-n/a (2024)
Abstract Background The surge in omicron variants has caused nationwide breakthrough infections in mainland China since the December 2022. In this study, we report the neutralization profiles of serum samples from the patients with breast cancer and
Externí odkaz:
https://doaj.org/article/83958743bd354ea19fec061b9fbbbd01
Autor:
Xiaopeng Hao, Zefei Jiang
Publikováno v:
Cancer Biology & Medicine, Vol 20, Iss 12, Pp 981-984 (2023)
Externí odkaz:
https://doaj.org/article/74d50b32d3354eadbe7af37978140083
Autor:
Feng Li, Jianbin Li, Yang Yuan, Huiqiang Zhang, Shaohua Zhang, Li Bian, Tao Wang, Zefei Jiang
Publikováno v:
Heliyon, Vol 10, Iss 7, Pp e29217- (2024)
Background: Both CellSearch and CellCollector have been accepted as the proper devices to capture CTC by domestic approval department. However, there is little article about the comparison between these two devices around the world. Herein, we conduc
Externí odkaz:
https://doaj.org/article/8aa9b6081aa244189bbec6da50568cd8
Autor:
Yang Yang, Yingjian He, Zhaoqing Fan, Xue Chen, Yiqiang Liu, Chao Zhang, Hongchuan Jiang, Xin Wang, Xiang Wang, Fei Xie, Shu Wang, Bin Luo, Hua Kang, Tao Wang, Zefei Jiang, Peng Yuan, Binhe Xu, Ling Xu, Yinhua Liu, Jinfeng Li, Yuntao Xie, Tianfeng Wang, Tao Ouyang
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-8 (2023)
Abstract There are few studies focus on post-neoadjuvant treatment in hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-)/lymph node-positive (LN+) breast cancer, a multi-center, open-label, randomized, controlle
Externí odkaz:
https://doaj.org/article/9b0d7af4be2244968e1e3b738e8ffcce
Autor:
Yang Yuan, Shaohua Zhang, Tao Wang, Li Bian, Min Yan, Yongmei Yin, Yuhua Song, Yi Wen, Jianbin Li, Zefei Jiang, Rongman Jia, Xiuyuan Hao
Publikováno v:
Chinese Medical Journal, Vol 136, Iss 12, Pp 1459-1467 (2023)
Abstract. Background:. Endocrine therapy (ET) and ET-based regimens are the preferred first-line treatment options for hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (HR+/HER2– M
Externí odkaz:
https://doaj.org/article/12de9c9dd66b4456b01f7fed46d3e1e3